Literature DB >> 32757412

A case of YAP1 and NUTM1 rearranged porocarcinoma with corresponding immunohistochemical expression: Review of recent advances in poroma and porocarcinoma pathogenesis with potential diagnostic utility.

Ourania Parra1, Darcy A Kerr1,2, Julia A Bridge3,4, Andrew P Loehrer2,5,6, Konstantinos Linos1,2.   

Abstract

Porocarcinoma is a rare malignant adnexal tumor with predilection for the lower extremities and the head and neck region of older adults. This entity may arise de novo or in association with a benign poroma. Porocarcinoma's non-specific clinical appearance, immunohistochemical profile, and divergent differentiation may occasionally be diagnostically challenging. Recently, highly recurrent YAP1 and NUTM1 gene rearrangements have been described in cases of poroma and porocarcinoma. In this report, we present a case of porocarcinoma with squamous differentiation in an 81-year-old woman which harbored rearrangement of the YAP1 and NUTM1 loci and was diffusely immunoreactive for NUTM1. We discuss the recent advancements in the pathogenesis of poromas and porocarcinomas with emphasis on the clinical utility of the NUTM1 antibody.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FISH; NUTM1; YAP1; porocarcinoma; poroma

Year:  2020        PMID: 32757412     DOI: 10.1111/cup.13832

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.

Authors:  Benjamin J Van Treeck; Judith Jebastin Thangaiah; Jorge Torres-Mora; Todd M Stevens; Christian Rothermundt; Matteo Fassan; Fotios Loupakis; Joachim Diebold; Jason L Hornick; Kevin C Halling; Andrew L Folpe
Journal:  Mod Pathol       Date:  2021-03-13       Impact factor: 7.842

Review 2.  Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors.

Authors:  Nicolas Macagno; Pierre Sohier; Thibault Kervarrec; Daniel Pissaloux; Marie-Laure Jullie; Bernard Cribier; Maxime Battistella
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.